Statland departure lengthens FDA's vacancies list
This article was originally published in Clinica
Vacancies abound for senior positions at the FDA. The Center for Devices and Radiological Health (CDRH) is losing another top official. Dr Bernard Statland, director of the Office of Device Evaluation, is leaving effective August 23 to complete his law degree at the University of Minnesota.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.